80 related articles for article (PubMed ID: 24852431)
1. The specific methylation characteristics of cancer related genes in Chinese colorectal cancer patients.
Yang W; Wang X; Li X; Wang M; Chen X; Wu X; Wang Y; Fan Y; Jin H
Tumour Biol; 2014 Aug; 35(8):8267-79. PubMed ID: 24852431
[TBL] [Abstract][Full Text] [Related]
2. The dynamic DNA methylation landscape of the
Savio AJ; Mrkonjic M; Lemire M; Gallinger S; Knight JA; Bapat B
Clin Epigenetics; 2017; 9():26. PubMed ID: 28293327
[TBL] [Abstract][Full Text] [Related]
3. Identification of epigenetic silencing of the SFRP2 gene in colorectal cancer as a clinical biomarker and molecular significance.
Boughanem H; Pilo J; García-Flores LA; Arranz I; Ramos-Fernandez M; Ortega-Castan M; Crujeiras AB; Sandoval J; Macias-Gonzalez M
J Transl Med; 2024 May; 22(1):509. PubMed ID: 38802858
[TBL] [Abstract][Full Text] [Related]
4. MLH1 region polymorphisms show a significant association with CpG island shore methylation in a large cohort of healthy individuals.
Savio AJ; Lemire M; Mrkonjic M; Gallinger S; Zanke BW; Hudson TJ; Bapat B
PLoS One; 2012; 7(12):e51531. PubMed ID: 23240038
[TBL] [Abstract][Full Text] [Related]
5. Association between variation of circulating 25-OH vitamin D and methylation of secreted frizzled-related protein 2 in colorectal cancer.
Boughanem H; Cabrera-Mulero A; Hernández-Alonso P; Clemente-Postigo M; Casanueva FF; Tinahones FJ; Morcillo S; Crujeiras AB; Macias-Gonzalez M
Clin Epigenetics; 2020 Jun; 12(1):83. PubMed ID: 32517740
[TBL] [Abstract][Full Text] [Related]
6. Tumor p16INK4 gene expression and prognosis in colorectal cancer.
Kitamura H; Takemura H; Minamoto T
Oncol Rep; 2019 Feb; 41(2):1367-1376. PubMed ID: 30483798
[TBL] [Abstract][Full Text] [Related]
7. The clinicopathological significance of
Wu Y; Gong L; Xu J; Mou Y; Xu X; Qian Z
Onco Targets Ther; 2017; 10():5827-5834. PubMed ID: 29263679
[TBL] [Abstract][Full Text] [Related]
8. The Circulating Level of Klotho Is Not Dependent upon Physical Fitness and Age-Associated Methylation Increases at the Promoter Region of the Klotho Gene.
Aczel D; Torma F; Jokai M; McGreevy K; Boros A; Seki Y; Boldogh I; Horvath S; Radak Z
Genes (Basel); 2023 Feb; 14(2):. PubMed ID: 36833453
[TBL] [Abstract][Full Text] [Related]
9. The effects of thymidylate synthase 3'UTR genotype on methylation of tumor-specific genes promoter in 22 colorectal cancer patients from southern Iran.
Niknam M; Naghibalhossaini F; Zamani M; Hosseini SV; Mokarram P
Mol Biol Res Commun; 2024; 13(2):89-102. PubMed ID: 38504782
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic Significance of Hypomethylated
Shalmashi H; Safaei S; Zarredar H; Asvadi Kermani T; Hashemzadeh S; Mehdi Navaz A
Adv Biomed Res; 2023; 12():241. PubMed ID: 38073736
[TBL] [Abstract][Full Text] [Related]
11. Klotho promoter methylation status and its prognostic value in ovarian cancer.
Al-Zahrani MH; Yahya FM; Assidi M; Dallol A; Buhmeida A
Mol Clin Oncol; 2021 Sep; 15(3):181. PubMed ID: 34277000
[TBL] [Abstract][Full Text] [Related]
12. DNA methylation is a common molecular alteration in colorectal cancer cells and culture method has no influence on DNA methylation.
Wang S; Huang Y; Mu X; Qi T; Qiao S; Lu Z; Li H
Exp Ther Med; 2018 Apr; 15(4):3173-3180. PubMed ID: 29545832
[TBL] [Abstract][Full Text] [Related]
13. Frequent loss of
Li S; Han T
iScience; 2024 May; 27(5):109646. PubMed ID: 38638566
[TBL] [Abstract][Full Text] [Related]
14. Determination of the Relationship Between DNA Methylation Status of
Osum M; Tosun O; Birtan H; Kalkan R
Balkan J Med Genet; 2023 Dec; 26(2):41-50. PubMed ID: 38482265
[TBL] [Abstract][Full Text] [Related]
15. Role of Fibroblast Growth Factor 23 (FGF23) and αKlotho in Cancer.
Ewendt F; Feger M; Föller M
Front Cell Dev Biol; 2020; 8():601006. PubMed ID: 33520985
[TBL] [Abstract][Full Text] [Related]
16. Association between SFRP promoter hypermethylation and different types of cancer: A systematic review and meta-analysis.
Yu J; Xie Y; Li M; Zhou F; Zhong Z; Liu Y; Wang F; Qi J
Oncol Lett; 2019 Oct; 18(4):3481-3492. PubMed ID: 31516566
[TBL] [Abstract][Full Text] [Related]
17. DNA methylation-mediated Klotho silencing is an independent prognostic biomarker of head and neck squamous carcinoma.
Zhu Y; Cao X; Zhang X; Chen Q; Wen L; Wang P
Cancer Manag Res; 2019; 11():1383-1390. PubMed ID: 30863149
[TBL] [Abstract][Full Text] [Related]
18. Klotho suppresses colorectal cancer through modulation of the unfolded protein response.
Arbel Rubinstein T; Shahmoon S; Zigmond E; Etan T; Merenbakh-Lamin K; Pasmanik-Chor M; Har-Zahav G; Barshack I; Vainer GW; Skalka N; Rosin-Arbesfeld R; Varol C; Rubinek T; Wolf I
Oncogene; 2019 Feb; 38(6):794-807. PubMed ID: 30232408
[TBL] [Abstract][Full Text] [Related]
19. Prognostic DNA methylation markers for sporadic colorectal cancer: a systematic review.
Draht MXG; Goudkade D; Koch A; Grabsch HI; Weijenberg MP; van Engeland M; Melotte V; Smits KM
Clin Epigenetics; 2018; 10():35. PubMed ID: 29564023
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of MLH1 promoter methylation in male patients with esophageal squamous cell carcinoma.
Wu D; Chen X; Xu Y; Wang H; Yu G; Jiang L; Hong Q; Duan S
Oncol Lett; 2017 Apr; 13(4):2745-2750. PubMed ID: 28454461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
